{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:37:38Z","timestamp":1774924658374,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10048-022-00687-4","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T13:39:23Z","timestamp":1644845963000},"page":"103-114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Experiences in the molecular genetic and histopathological evaluation of calpainopathies"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2654-3698","authenticated-orcid":false,"given":"Berk","family":"Ozyilmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozgur","family":"Kirbiyik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha R.","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozge Kaya","family":"Ozer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasar B.","family":"Kutbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadri M.","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merve Saka","family":"Guvenc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eener","family":"Ar\u0131kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuba Sozen","family":"Turk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat Y\u0131ld\u0131r\u0131m","family":"Kale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irem Fatma","family":"Uludag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Figen","family":"Baydan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filiz","family":"Sertpoyraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"Gencpinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulden","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"issue":"5","key":"687_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/ahg.12319","volume":"83","author":"B \u00d6zyilmaz","year":"2019","unstructured":"\u00d6zyilmaz B et al (2019) Impact of next-generation sequencing panels in the evaluation of limb-girdle muscular dystrophies. Ann Hum Genet 83(5):331\u2013347","journal-title":"Ann Hum Genet"},{"issue":"1","key":"687_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0092-8674(95)90368-2","volume":"81","author":"I Richard","year":"1995","unstructured":"Richard I et al (1995) Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81(1):27\u201340","journal-title":"Cell"},{"issue":"s2","key":"687_CR3","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.3233\/JND-150105","volume":"2","author":"AP Murphy","year":"2015","unstructured":"Murphy AP, Straub V (2015) The classification, natural history and treatment of the limb girdle muscular dystrophies. J Neuromuscul Dis 2(s2):S7\u2013S19","journal-title":"J Neuromuscul Dis"},{"key":"687_CR4","first-page":"635","volume-title":"Neuromuscular disorders of infancy, childhood, and adolescence","author":"P Mohassel","year":"2015","unstructured":"Mohassel P, B\u00f6nnemann CG (2015) Limb-girdle muscular dystrophies. Neuromuscular disorders of infancy, childhood, and adolescence. Elsevier, pp 635\u2013666"},{"key":"687_CR5","doi-asserted-by":"crossref","unstructured":"Pathak P et al (2020) Mutational spectrum of CAPN3 with genotype-phenotype correlations in limb girdle muscular dystrophy type 2A\/R1 (LGMD2A\/LGMDR1) patients in India. J Neuromuscul Dis, (Preprint): p. 1\u201312","DOI":"10.3233\/JND-200547"},{"issue":"4","key":"687_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/acn3.287","volume":"3","author":"I Richard","year":"2016","unstructured":"Richard I et al (2016) Natural history of LGMD 2A for delineating outcome measures in clinical trials. Ann Clin Transl Neurol 3(4):248\u2013265","journal-title":"Ann Clin Transl Neurol"},{"key":"687_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/B978-0-08-045031-5.00006-2","volume":"101","author":"E Gallardo","year":"2011","unstructured":"Gallardo E, Saenz A, Illa I (2011) Limb-girdle muscular dystrophy 2A. Handb Clin Neurol 101:97\u2013110","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"687_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jmb.2011.01.057","volume":"407","author":"K Ojima","year":"2011","unstructured":"Ojima K et al (2011) Non-proteolytic functions of calpain-3 in sarcoplasmic reticulum in skeletal muscles. J Mol Biol 407(3):439\u2013449","journal-title":"J Mol Biol"},{"issue":"2","key":"687_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mus.20586","volume":"34","author":"A Aartsma-Rus","year":"2006","unstructured":"Aartsma-Rus A et al (2006) Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve: Official Journal of the American Association of Electrodiagnostic Medicine 34(2):135\u2013144","journal-title":"Muscle Nerve: Official Journal of the American Association of Electrodiagnostic Medicine"},{"issue":"5","key":"687_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013423","journal-title":"Genet Med"},{"issue":"3","key":"687_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10048-008-0129-1","volume":"9","author":"L Bl\u00e1zquez","year":"2008","unstructured":"Bl\u00e1zquez L et al (2008) Characterization of novel CAPN3 isoforms in white blood cells: an alternative approach for limb-girdle muscular dystrophy 2A diagnosis. Neurogenetics 9(3):173\u2013182","journal-title":"Neurogenetics"},{"issue":"7","key":"687_CR12","doi-asserted-by":"publisher","first-page":"e102549","DOI":"10.1371\/journal.pone.0102549","volume":"9","author":"MI Nilsson","year":"2014","unstructured":"Nilsson MI et al (2014) Redox state and mitochondrial respiratory chain function in skeletal muscle of LGMD2A patients. PLoS One 9(7):e102549","journal-title":"PLoS One"},{"issue":"12","key":"687_CR13","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/acn3.649","volume":"5","author":"BRR Nallamilli","year":"2018","unstructured":"Nallamilli BRR et al (2018) Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients. Ann Clin Transl Neurol 5(12):1574\u20131587","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"687_CR14","first-page":"210","volume":"37","author":"U Y\u0130\u015f","year":"2018","unstructured":"Y\u0130\u015f U et al (2018) Childhood onset limb-girdle muscular dystrophies in the Aegean part of Turkey. Acta Myologica. 37(3):210","journal-title":"Acta Myologica."},{"issue":"1","key":"687_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-014-0154-7","volume":"14","author":"K Stehl\u00edkov\u00e1","year":"2014","unstructured":"Stehl\u00edkov\u00e1 K et al (2014) Autosomal recessive limb-girdle muscular dystrophies in the Czech Republic. BMC Neurol 14(1):1\u20139","journal-title":"BMC Neurol"},{"issue":"5","key":"687_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/jmg.37.5.361","volume":"37","author":"P Din\u00e7er","year":"2000","unstructured":"Din\u00e7er P et al (2000) A cross section of autosomal recessive limb-girdle muscular dystrophies in 38 families. J Med Genet 37(5):361\u2013367","journal-title":"J Med Genet"},{"key":"687_CR17","doi-asserted-by":"crossref","unstructured":"Zhong H et al (2020) Molecular landscape of CAPN3 mutations in limb-girdle muscular dystrophy type R1: from a Chinese multicentre analysis to a worldwide perspective. J Med Genet","DOI":"10.1136\/jmedgenet-2020-107159"},{"issue":"4","key":"687_CR18","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/brain\/awh408","volume":"128","author":"A Saenz","year":"2005","unstructured":"Saenz A et al (2005) LGMD2A: genotype\u2013phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain 128(4):732\u2013742","journal-title":"Brain"},{"issue":"04","key":"687_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1055\/s-2007-973702","volume":"28","author":"H Topalo\u01e7lu","year":"1997","unstructured":"Topalo\u01e7lu H et al (1997) Calpain-3 deficiency causes a mild muscular dystrophy in childhood. Neuropediatrics 28(04):212\u2013216","journal-title":"Neuropediatrics"},{"issue":"5","key":"687_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00431-005-0046-3","volume":"165","author":"B Balci","year":"2006","unstructured":"Balci B et al (2006) Calpain-3 mutations in Turkey. Eur J Pediatr 165(5):293\u2013298","journal-title":"Eur J Pediatr"},{"issue":"11","key":"687_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1089\/gtmb.2015.0131","volume":"19","author":"M Dorobek","year":"2015","unstructured":"Dorobek M et al (2015) The frequency of c. 550delA mutation of the CANP3 gene in the Polish LGMD2A population. Genet Test Mol Biomark 19(11):637\u2013640","journal-title":"Genet Test Mol Biomark"},{"issue":"2","key":"687_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/mus.24682","volume":"52","author":"M Fanin","year":"2015","unstructured":"Fanin M, Angelini C (2015) Protein and genetic diagnosis of limb girdle muscular dystrophy type 2A: the yield and the pitfalls. Muscle Nerve 52(2):163\u2013173","journal-title":"Muscle Nerve"},{"issue":"1","key":"687_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-016-1058-z","volume":"17","author":"I Inashkina","year":"2016","unstructured":"Inashkina I et al (2016) Robust genotyping tool for autosomal recessive type of limb-girdle muscular dystrophies. BMC Musculoskelet Disord 17(1):1\u20136","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"687_CR24","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/humu.24066","volume":"41","author":"J Vissing","year":"2020","unstructured":"Vissing J et al (2020) A single c. 1715G> C calpain 3 gene variant causes dominant calpainopathy with loss of calpain 3 expression and activity. Human Mutat 41(9):1507\u20131513","journal-title":"Human Mutat"},{"issue":"6","key":"687_CR25","first-page":"1","volume":"23","author":"C Zhang","year":"2021","unstructured":"Zhang C et al (2021) Compound heterozygous CAPN3 variants identified in a family with limb-girdle muscular dystrophy recessive 1. Mol Med Rep 23(6):1\u20138","journal-title":"Mol Med Rep"},{"issue":"9","key":"687_CR26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/jmg.2004.028738","volume":"42","author":"G Piluso","year":"2005","unstructured":"Piluso G et al (2005) Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes. J Med Genet 42(9):686\u2013693","journal-title":"J Med Genet"},{"issue":"3","key":"687_CR27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.nmd.2004.11.003","volume":"15","author":"M Fanin","year":"2005","unstructured":"Fanin M et al (2005) The frequency of limb girdle muscular dystrophy 2A in northeastern Italy. Neuromuscul Disord 15(3):218\u2013224","journal-title":"Neuromuscul Disord"},{"issue":"15","key":"687_CR28","first-page":"4941","volume":"25","author":"N Alharbi","year":"2021","unstructured":"Alharbi N et al (2021) Clinical and genetic features of calpainopathies in Saudi Arabia\u2013a descriptive cross-sectional study. Eur Rev Med Pharmacol Sci 25(15):4941\u20134952","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"687_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0960-8966(00)00143-7","volume":"10","author":"LV Anderson","year":"2000","unstructured":"Anderson LV et al (2000) Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord 10(8):553\u2013559","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"687_CR30","first-page":"259","volume":"28","author":"G Diniz","year":"2012","unstructured":"Diniz G et al (2012) A regional panorama of dysferlinopathies. Turk Patoloji Derg 28(3):259\u2013265","journal-title":"Turk Patoloji Derg"},{"issue":"1","key":"687_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2044-5040-1-1","volume":"1","author":"R Han","year":"2011","unstructured":"Han R (2011) Muscle membrane repair and inflammatory attack in dysferlinopathy. Skelet Muscle 1(1):1\u20138","journal-title":"Skelet Muscle"}],"container-title":["neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-022-00687-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-022-00687-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-022-00687-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T14:10:11Z","timestamp":1648476611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-022-00687-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1007\/s10048-022-00687-4","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"assertion":[{"value":"16 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical publication statement"}},{"value":"The study was not submitted to a research ethics committee. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975 (in its most recently amended version). Informed consent was obtained from all patients included in the study. Additional informed consent was obtained from all patients for whom identifying information is included in this article. All institutional and national guidelines for the care and use of laboratory animals were followed. This article does not contain any studies with human or animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}